New Therapeutic Strategies againstHelicobacter pylori

Steroidsmediate resistance to thebactericidal e¡ectof phosphatidylcholines againstHelicobacter pylori

Steroidsmediate resistance to thebactericidal e¡ectof phosphatidylcholines againstHelicobacter pylori Hirofumi Shimomura, Kouichi Hosoda, Shunji Hayashi, Kenji Yokota, Keiji Oguma & Yoshikazu Hirai Department of Infection and Immunity, Division of Bacteriology, Jichi Medical University, Tochigi, Japan; and Department of Bacteriology, Graduate School of Medicine, Dentistry and Pharmacology, Okay...

juxtapapillary retinal capillary hemangioma: new therapeutic strategies

the treatment of juxtapapillary retinal capillary hemangiomas (jrchs) is still a therapeutic dilemma without established guidelines. because of the location of these hemangiomas on or adjacent to the optic nerve, treatment is difficult and complex, especially when jrchs are located in the papillomacular bundle. this manuscript reviews the clinically relevant data on literature regarding the tre...

New strategies for Helicobacter pylori eradication.

Helicobacter pylori infection is highly prevalent worldwide and is a major cause of diseases occurring in the upper gastrointestinal tract. Successful eradication therapy improves H. pylori-related symptoms in functional dyspepsia, cures peptic ulcer disease and may prevent gastric cancer. During the past decade, the success rate of recommended eradication regimens declined from over 90% to abo...

New therapeutic strategies for raltegravir.

Raltegravir (Isentress) is the first approved HIV integrase inhibitor. Agents in this class target a different viral enzyme compared with agents inhibiting reverse transcriptase and protease. A wide number of patients are currently susceptible to integrase inhibitors, including heavily antiretroviral-experienced patients harbouring drug-resistant viruses. The good tolerability and convenience o...

Helicobacter pylori — Current Therapy and Future Therapeutic Strategies